News
Jan. 16, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB) (Seres or the Company), a leading live biotherapeutics company, announced today the receipt of a $50 million installment ...
Ltd. (“Vista Australia”) has received the first installment payment of $3 million (“First Installment”) under the royalty agreement between Vista Australia and Wheaton Precious Metals ...
CAMBRIDGE, Mass., Jan. 16, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB) (Seres or the Company), a leading live biotherapeutics company, announced today the receipt of a $50 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback